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Hailey-Hailey disease (HHD) is a rare autosomal dom-
inant genodermatosis characterized by disturbed ke-
r atinocyte adhesion. The disease has recently been 
mapped to a 14cM region on chromosome 3q. We 
have further refined the location of the HHD gene by 
linkage analysis in six HHD families from Germany 
and Italy using 11 polymorphic microsatellite mark-
ers and found no evidence for genetic heterogeneity. 
H ailey-Hailey disease (HHD; familial benign chronic pe mphigus) is a rare autosom al dominant genoder-matosis characterized b y abnormal epithelial cell adhesion involving th e epidermis and, more rarely, th e mucous m embranes [1- 6). C linical symptoms 
present after p ube rty, with peak onset in the second to fourtl1 
decades of life [2,3,7). Skin lesions may b egin with a transient phase 
of superficial blistering and rapidly progress to expanding erythem-
atou s, scaly plaques with fissures and cruste d e rosions. These 
usually alfect the intertriginous and flex u ral areas of the body , but 
can b e widespread or generalized [8) . Mino r trauma (friction, heat, 
sweat), inflammatio n , or infection can induce or exacerbate the 
clinical symptoms ofHHD. In gene ral, the disease follows a chronic 
recurrent course, often leading to discomfort, p ain, and limitation 
of physical activities. 
The m ajor histologic feature ofHHD is a widespread separation 
of the suprabasal kerati.nocytes of the epidermis (acantholysis) , 
leading to intraepidermal lacunae, splits, and blisters. Dyskeratosis 
(abnormal keratinization of keratinocytes) , acanthosis of the epi-
dermis, and a mild pe rivascular inflammation of the upper d ermis 
may be present [9). Ultrastructural and immunofluorescence studies 
of lesion a! skin have revea led a loss of cell adhesion with dissoci-
ation and inte rnalization of desmosoma1 components, breakdown 
of the d esmosom e-keratin intermediate fil am ent complex, and 
abnormal perinuclear aggregation of keratin intennediate filaments 
[10 -14) . The pathogenes is of disturbed ker.atinocyte attachment 
and the underlying molecular d efect remain to b e e lucidate d. 
We h ave used a gen etic linkage analysis to localize the HHD 
gene. Our early Linkage studies excluded several candidate genes 
known to be involved in epithelial diffe rentiation and cell adhesion, 
as well as the Darier disease locus [15). Although 1-IHD and Darier 
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We observed complete cosegregation between HHD 
and marker D3S1587, with a maximal lod score of 
4.54. Detailed haplotype analyses allowed us to nar-
row the interval containing the HHD locus to ScM, 
flanked by D3S1589 and D3S1290. Key JVords: gmoder-
matosislepidermis!litlkagelfamilial bet1ig11 chronic pemphi-
gus. J Ir~vest Dermatol 105:357-360, 1995 
disease share several cotnnlon histologic and pathogenetic features, 
these genodermatoses are not al.l e lic disorders. Recently, Ikeda eta/ 
[16) used a rand o m marker search and localized the HHD gen e to 
a 14cM interval on chromosom e 3 q21-q24. 
We confinn the linkage ofHI-ID in six mu.ltigenerational families 
to chromosom e 3q21-q24. T lus location for HHD is consisten t in 
all fa milies reported to date, suggesting genetic homogeneity. 
R ecombinatio n between the disease locus and several marke rs 
tes ted narrows the location o f the HHD gene to a 5- cM interval 
Ranke d by the loci 0351589 and 0351290. 
MATERIALS AND METHODS 
Clinical Study We studied six un.related f.1milies with HHD (five from 
Gennany and one from Italy). T he diagnosis of HHD was established by 
dermatologic examination and conf:inn ed by light microscopic investiga-
tions of cutaneous biopsy specimens in at least two affected individuals from 
each f;nnily. Blood samples were obtained fro m 26 affected and 36 
unaJfected individuals for the purpose of DNA extraction. 
DNA Analysis Genomic DNA was isolated by standard methods (17] 
and was amplified using polyme.rase chain reaction methodology. Reactions 
were performed in a volume of20 J.Ll containing 50-100 ng genomic DNA; 
150 nM of each primer; 200 J.LM each of dA TP, dGTP, and dTTP; 25 ~-tM 
dCTP; 0.066 ~-tl of 32P-dCTP (3000 Ci/ mmol) ; 10 mM Tris-H Cl (pH 8.3); 
50 mM KCl ; 1.5 mM MgC12 ; and 0.1 U of Taq polymerase (Boehringer-
Mannheim), overla id by mineral oil. After initial denaturation at 94 °C for 2 
min. cycle conditions were 94°C for 1 min, ssoc for 1 min, and 72°C for 
1 min and 30 seconds (35 cycles), followed by a 10-min final extension srep 
at 72°C. T he amplified DNA was separated on 6% sequencing gels (6 M 
urea) under standard electrophoretic conditions. Autoradiographs of dried 
gels were interpreted independently by two investigators. 
Markers analyzed included 11 highly polymorphic anonymous dinucle-
otide and tetranucleotide repeats . ordered as follows: D3Sl589-
ScM-D3S1587-0cM-D3S1 292-0cM-D3S1273-0cM-D3S1290-
t .8 cM-D3St238-3.2cM-D3S1549-0cM-D3S 1576 -l cM-
D3S1316-0cM-D3S1615, and D3S1764 between D3S1238 and D3S1549/ 
D3S1576. The order and sex-averaged distances were derived from several 
sonrces (1 8 - 20] ;md are shown in Fig 1. 
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Figure 1. Map of markers on chromosome 3q used for linkage 
analysis. Approximate location along chromosome 3 is shown on the 
ideogram. Order and distances for the markers were derived from maps 
published by the Cooperative Human Linkage Centre and Genethon 
[17 ,28]. 
Linkage Analysis Pairwise linkage analyses between each marker and 
the disease locus were performed using the LINKAGE program [21]. HI-10 
was modeled as an autosomal dominant disorder with a disease allele 
frequency of 1:100,000. Because the probability of diagnosing HHD is age 
dependent, six liability classes were defined as follows: age 0-10, 0.0001; 
age 11-20, 0.15; age 21-30, 0.60; age 31-40, 0.85; age 41-50, 0.95; and age 
50 or older, 0.99 [2,3, 7]. Individuals with an uncertain clinical phenotype 
were coded as "unknown" for all analyses. Marker aUcle frequencies were 
established from a series of unaffected controls or published sources. 
RESULTS 
Six families were tested for linkage of HHD to the region of 
chromosome 3q21-q24. We initially used 11 dinucleotide and tetra-
nucleotide repeat polymorphisms between D3S1S89 and D3S161S, 
spanning approximately 11cM according to current genetic maps 
(Fig 1) [18,19] . Maximum likelihood estimates of the recombina-
tion fraction and lod scores for each marker are shown in Table I. 
Lod scores greater than 3 were obtained for seven markers, 
Table I. Pairwise Lod Scores for Hailey-Hailey Disease 
Versus 11 Markers on Chromosome 3q 
Number of 
Informative 
Locus 0.00 0.10 0.20 0.30 Z" 0" Families 
0351589 -0.99 2.29 1.90 1.14 2.29 0.09 4 
0351587 4.54 3.80 2.83 1.73 4.54 0.00 5 
03S1292 2.62 4.98 3.84 2.41 5.32 0.04 5 
D3S1273 3.36 5.52 4.12 2.54 6.10 0.03 5 
03S1290 - 2.81 3.83 3.05 1.94 3.90 0.07 4 
0351238 - 3.76 3.33 2.65 1.65 3.38 0.07 6 
D3S1764 - 8.62 2.21 2.06 1.38 2.26 0.13 5 
D3S1576 - 4.84 1.85 1.49 0.90 1.85 0.09 4 
03S1549 0.10 2.95 2.15 1.27 3.20 0.04 4 
03S1 316 - 3.65 3.56 3.56 1.57 3.83 0.04 5 
D3S1615 - 1.94 0.85 0.61 0.32 0.87 0.08 3 
1
' Z, 0. maximum likelihood csti1nates of lod score and recombination fr:tctic.n . 
THE JOUI~AL OF INVESTIGATIVE DERMATOLOGY 
confirming the location of HHD to this chromosomal region . Of 
these markers, complete cosegregation was found between HHD 
and the locus D3S1587 (Z = 4.S4). 
To define more precisely the location of the HHD gene, we 
identified recombinant chromosomes by haplotype construction. 
The most likely haplotypes for each fumily were deduced for the 
typed markers. There were two families in which a recombination 
event provided information for placement of the disease locus (Fig 
2). A proximal bonndary was determined by a recombination 
between HHD and D3S1S89, presenting in the affected individual 
IV-2, family H002. The distal boundary for the HHD locus could 
be established from recombination in family I-!001 , in which an 
unusual number of recombinant chromosomes was found (Fig 2) . 
Among affected individuals, recombination between D3S1238 and 
D3S1764 was observed in 11-S and lll-4, between D3S1290 and 
D3S1238 in Ill-1, and between D3S1273/D3S1292/D3S1S87 and 
D3S1290 in III-8. These m eiotic recombination events place the 
disease locus proximal to D3S1290. The region harboring the HHD 
locus is therefore defined by a ScM interval between D3S1589 and 
D3S1290 . 
Several unaffected individuals in our families inherited a recom-
binant disease chromosome within the candidate region (i.e., Fig 2, 
HOOl-IV-2, HOOl-IV- 5). Because of the age-dependent penetrance 
in HHD, however, these events do not provide further de finitive 
information regarding location of the disease gene. We also 
observed four clinically unaffected individuals (at ages 12, 26, 36, 
and 61) who inherited the entire chromosomal region containing 
the HHD locus from an affected parent. 
DISCUSSION 
The results of our pairwise lod score analysis in six families place 
HHD in the region 3q21-q24 within the previously reported 
interval flanked by D3S1589 and D3S161S [16]. Detailed haplo type 
analysis of recombinant chromosomes further refined the mapping 
of HHD. We observed recombination between the disease locus 
and D3S1S89, confirming tlus marker as the centromeric boundary . 
In addition, recombination of the disease locus with several mark-
ers, including D3S1238 and D3S1290, allowed us to establish 
D3S1290 as the distal boundary for HI-fD, placing the gene 
between D3S1S89 and D3S1290. 
The interval between these flanking markers spa ns approxi-
mately ScM [18]. The four markers D3S1290, D3S1273, D3S1292 , 
and D3S1S87 have not been ordered previously [1 8,19]. We have 
now identified three recombination events among these loci: Two 
events (on nondisease chromosomes) separate D3S1S87/D3S1292 
from D3S1290/ D3S1273 (individuals H009-III-1 and HOll-lii-7; 
data not shown), and one separates D3S1290 from the other three 
loci (individual HOOl-III-8; Fig 2). These recombinations therefore 
order the markers as cen-D3S1S87/D3S1292-D3S 1273-D3S1290-
tel, as shown in Fig 1. 
It is interesting that the haplotypes for family H001 predicted five 
separate recombination events in 18 meioses witlun the llcM 
interval (a germ line event is ass umed in generation I). The data 
supporting these haplotypes (Fig 2) were checked thoroughly, and 
the haplotypes were constructed to minimize the number of 
recombination events. This high frequency of meioti.c crossover 
may represent a chance occurrence or increased recombination 
activity in this family. However, the haplotypes presented in Fig 2 
as well as the less likely alternative haplotypes (data not shown) do 
not change for individual H001-lll-8, whose recombination evem 
identifies D3S1290 as the distal flanking marker. 
Carriers of the HHD gene can be detected in informative families 
based on haplotype analys is, and therefore the possibi.lity of genetic 
counseling and prenatal diagnosis can now be considered. We 
fonnd four individuals who inherited the whole disease chromo-
some from 3q2l to 3q24. Each can be predicted to carry the HHD 
gene and eventually to develop the disease, although dermatologic 
examination of three individuals at ages 12, 26, and 36 indicated no 
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Figure 2. Pedigrees of two families with H1-ID showing disease status and genotypes for markers on chromosome 3q. Pare11theses, ages of 
individuals in the youngest generation; solid boxes, haplotype carrying the HHD gene in each family; brackets, deduced haplorypes for deceased individuals. 
Haplorypes were constructed based on the reported marker order and to mininuze the number of double recombination events between close markers . 
Arrows, recombination events between adjacent markers in the parental chromosome, which narrow ·the interval harboring the HHD gene. 
clinical evidence ofHHD. A fourth individual, not examined by us, 
has at age 61 already passed well beyond the usual age of onset for 
HHD (H002-III-1 ; Fig 2) . Her medical history revealed that she 
had occasionally suffered transient erythematous skin lesions, al-
though these had never caused her to seek medical attention. It is 
possible, therefore, that she is affected by a very mild form of the 
disease. Alternatively, she may represent an event of incomplete 
gene penetrance, which has been reported to occur rarely in HHD 
[22-24] . 
The age at onset, morphologic pattern, and severity ofHHD are 
known to vary between and within families (2,3, 7]. In our cohort, 
we observed disease onset between 1.4 and 53 years of age. In two 
thirds of our patients, the disease manifested be tween ages 20 and 
40 years . Our patient sample also included individuals affected with 
unusual bullous variants and atypical vulval and vaginal involve-
ment, as are occasionally reported (4,5,25-27). Despite these 
clinical variations, HHD is linked to the same chromosomal region 
in all these families and appears to be a genetically homogeneous 
disorder. In three families , we observed that some patients had 
severe or generalized involvement, whereas other family m embers 
were affected with only moderate or mild forms of tl1e disease. 
Although external stimuli may induce lesions in HHD, they are not 
sufficient to acco·unt for the observed intrafamilial variations of 
HHD. Differences in the individual genetic background on which 
the HHD gene is expressed may be another explanation. As for 
other diseases, the cause of variable clinical expression of HHD is 
poorly understood, and it is hoped that the nature of the defective 
gene will provide clues. 
Several genes have been assigned to 3q21-q24, altl1ough none is 
known to encode cytoskeleta.l, desmosomal, or cell adhesion 
proteins. Only cellular retinol binding protein 1, mapping in this 
region (28], is involved in the regulation of epidern1al dilferentia-
tion, but no mutation in the coding sequence of retinol binding 
protein 1 has been detected by single-strand conformation poly-
morphism in patients with HHD [29). It is probable that positional 
cloning will be necessary to identiry the HHD gene. To facilitate 
tlus approach, close Ranking markers will be required . In the 
present report, we -have refined the location of HHD to a ScM 
interval on chromosome 3q21, de fined by the loci D3S1589 and 
D3S1290. Although this is still a large distance, the development of 
new polymorphic markers within tlus region will allow furtl1er 
refmement of tl1e HHD locus . 
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